Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
Is a |
dexbrompheniraminmaleat |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
Is a |
dextromethorphanhydrobromid |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dexbrompheniramine maleate (substance) |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dextromethorphan hydrobromide (substance) |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
Is a |
phenylpropanolaminhydrochlorid |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
Is a |
brompheniraminmaleat |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Brompheniramine (substance) |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenylpropanolamine hydrochloride |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
Is a |
brompheniraminmaleat + dextromethorphanhydrobromid + phenylpropanolaminhydrochlorid |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Brompheniramine maleate |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
Has manufactured dose form |
oral væske |
false |
Inferred relationship |
Some |
|
|
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Some |
|
|